• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.01% Nasdaq Up0.26%

    Nuvo Research Inc. (NRI.TO)

    6.80 Up 0.15(2.26%) Nov 25
    ProfileGet Profile for:
    Nuvo Research Inc.
    7560 Airport Road
    Unit 10
    Mississauga, ON L4T 4H4
    Canada - Map
    Phone: 905-673-6980
    Fax: 905-673-1842
    Website: http://www.nuvoresearch.com

    Index Membership:N/A
    Full Time Employees:72

    Business Summary 

    Nuvo Research Inc., a specialty pharmaceutical company, researches, develops, and commercializes pharmaceutical products in Europe, Asia, and South America. The company has four commercialized products; a pipeline of topical and transdermal products focusing on various therapeutic areas, including pain and dermatology; and multiple drug delivery platforms that support the development of patented formulations that can deliver actives into or through the skin. Its topical pain products include Pennsaid, a non-steroidal anti-inflammatory drug that is used for the treatment of the pain of knee osteoarthritis; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of pain of knee osteoarthritis; and Pliaglis, a topical local anaesthetic cream, which provides local dermal anaesthesia on intact skin prior to superficial dermatological procedures, such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal, as well as heated lidocaine/tetracaine patch, a topical patch that provides local dermal analgesia for superficial venous access and superficial dermatological procedures. The company’s immunology products comprise WF10, an immune system modulating drug containing chlorite and chlorate ions; and Oxoferin, a topical wound healing agent containing the active ingredient in WF10 at a lower concentration. The company was formerly known as Dimethaid Research Inc. and changed its name to Nuvo Research Inc. in September 2005. The company was founded in 1983 and is based in Mississauga, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Nuvo Research Inc.

    Key Executives 
    Mr. Daniel N. Chicoine B.Comm., CPA, C.A.,
    Chairman and Co-Chief Exec. Officer
    Mr. John C. London LLB, LLM,
    Co-Chief Exec. Officer, Pres and Director
    Mr. Stephen L. Lemieux BA, MMPA, CPA, CA,
    Chief Financial Officer and VP
    Ms. Katina K. Loucaides M.Sc., LL.B,
    VP, Gen. Counsel and Corp. Sec.
    Dr. Henrich R. K. Guntermann M.D., M.Sc,
    Director and Pres of Europe & Immunology Group
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.
    View Insiders